{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:23:17Z","timestamp":1740172997370,"version":"3.37.3"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS064330","NS086134"],"award-info":[{"award-number":["NS064330","NS086134"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007172","name":"Cincinnati Children's Hospital Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007172","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Pilot Award"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.omtm.2018.10.001","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:19:45Z","timestamp":1539130785000},"page":"52-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Getting the Most: Enhancing Efficacy by Promoting Erythropoiesis and Thrombopoiesis after Gene Therapy in Mice with Hurler Syndrome"],"prefix":"10.1016","volume":"11","author":[{"given":"Jing-fen","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim S.","family":"El-Amouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2018.10.001_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tins.2011.05.006","article-title":"Clarifying lysosomal storage diseases","volume":"34","author":"Schultz","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.omtm.2018.10.001_bib2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrd.2017.214","article-title":"Emptying the stores: lysosomal diseases and therapeutic strategies","volume":"17","author":"Platt","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2018.10.001_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11011-012-9302-1","article-title":"Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms","volume":"27","author":"Campos","year":"2012","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.omtm.2018.10.001_bib4","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2174\/138920111795542679","article-title":"Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses","volume":"12","author":"Pan","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.omtm.2018.10.001_bib5","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/stem.716","article-title":"Concise review: managing genotoxicity in the therapeutic modification of stem cells","volume":"29","author":"Baum","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.omtm.2018.10.001_bib6","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ymthe.2017.03.025","article-title":"Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications","volume":"25","author":"Biffi","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2018.10.001_bib7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10545-017-0052-4","article-title":"Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I","volume":"40","author":"Penati","year":"2017","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2018.10.001_bib8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2018.10.001_bib9","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2018.10.001_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.stem.2013.08.006","article-title":"Broadening the indications for hematopoietic stem cell genetic therapies","volume":"13","author":"Williams","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2018.10.001_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T\u00a0cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.omtm.2018.10.001_bib12","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2018.10.001_bib13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1182\/blood-2011-09-349993","article-title":"Hematopoietic stem cell engineering at a crossroads","volume":"119","author":"Rivi\u00e8re","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.10.001_bib14","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1089\/hum.2017.141","article-title":"Promises and Challenges in Hematopoietic Stem Cell Gene Therapy","volume":"28","author":"Kohlscheen","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2018.10.001_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","article-title":"Platelet\u00a0alpha-granules: basic biology and clinical correlates","volume":"23","author":"Blair","year":"2009","journal-title":"Blood Rev."},{"key":"10.1016\/j.omtm.2018.10.001_bib16","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI26674","article-title":"The molecular mechanisms that control thrombopoiesis","volume":"115","author":"Kaushansky","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2018.10.001_bib17","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2010-03-272419","article-title":"Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A","volume":"116","author":"Shi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.10.001_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/path.3021","article-title":"The cellular pathology of lysosomal diseases","volume":"226","author":"Cox","year":"2012","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.omtm.2018.10.001_bib19","doi-asserted-by":"crossref","first-page":"19958","DOI":"10.1073\/pnas.0908528106","article-title":"Reprogramming erythroid cells for lysosomal enzyme production leads to visceral and CNS cross-correction in mice with Hurler syndrome","volume":"106","author":"Wang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2018.10.001_bib20","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1073\/pnas.1323155111","article-title":"Platelets are efficient and protective depots for storage, distribution, and delivery of lysosomal enzyme in mice with Hurler syndrome","volume":"111","author":"Dai","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"R1","key":"10.1016\/j.omtm.2018.10.001_bib21","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1093\/hmg\/ddr142","article-title":"Gene therapy for leukodystrophies","volume":"20","author":"Biffi","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2018.10.001_bib22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.crvi.2007.04.003","article-title":"[Cell therapy for inherited diseases of the hematopoietic system]","volume":"330","author":"Cavazzana-Calvo","year":"2007","journal-title":"C.\u00a0R. Biol."},{"key":"10.1016\/j.omtm.2018.10.001_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MOH.0000000000000377","article-title":"Is there a standard-of-care for transfusion support of patients with haematological malignancies?","volume":"24","author":"Zhao","year":"2017","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.omtm.2018.10.001_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/79194","article-title":"In\u00a0vivo selection using a cell-growth switch","volume":"26","author":"Jin","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2018.10.001_bib25","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1182\/blood-2002-03-0792","article-title":"Pharmacologically regulated in\u00a0vivo selection in a large animal","volume":"100","author":"Neff","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.10.001_bib26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/mt.2011.8","article-title":"Long-term regulation of genetically modified primary hematopoietic cells in dogs","volume":"19","author":"Okazuka","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2018.10.001_bib27","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1634\/stemcells.2005-0484","article-title":"Anatomical compartments modify the response of human hematopoietic cells to a mitogenic signal","volume":"24","author":"Nagasawa","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.omtm.2018.10.001_bib28","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1182\/blood-2014-02-555318","article-title":"A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor","volume":"125","author":"Belay","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.10.001_bib29","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/mt.2014.152","article-title":"Normalization and improvement of CNS deficits in mice with Hurler syndrome after long-term peripheral delivery of BBB-targeted iduronidase","volume":"22","author":"El-Amouri","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2018.10.001_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0168-1702(02)00355-6","article-title":"Viruses in therapy--royal road or dead end?","volume":"92","author":"Dobbelstein","year":"2003","journal-title":"Virus Res."},{"key":"10.1016\/j.omtm.2018.10.001_bib31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtm.2018.10.001_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1526-0968.2001.005001017.x","article-title":"Status of platelet collection and platelet transfusion","volume":"5","author":"Omokawa","year":"2001","journal-title":"Ther. Apher."},{"key":"10.1016\/j.omtm.2018.10.001_bib33","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1182\/blood-2008-01-134619","article-title":"Cell expansion and maintenance of stemness","volume":"111","author":"Kaushansky","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.10.001_bib34","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1126\/science.1148946","article-title":"Immunology. The root of platelet production","volume":"317","author":"Geddis","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.omtm.2018.10.001_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ymthe.2005.01.019","article-title":"Intrapulmonary and intramyocardial gene transfer in rhesus monkeys (Macaca mulatta): safety and efficiency of HIV-1-derived lentiviral vectors for fetal gene delivery","volume":"12","author":"Tarantal","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2018.10.001_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10856-017-5844-4","article-title":"Subcutaneous implantation of microencapsulated cells overexpressing \u03b1-L-iduronidase for mucopolysaccharidosis type I treatment","volume":"28","author":"Lizzi Lagranha","year":"2017","journal-title":"J.\u00a0Mater. Sci. Mater. Med."},{"key":"10.1016\/j.omtm.2018.10.001_bib37","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jama.2015.3253","article-title":"Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome","volume":"313","author":"Hacein-Bey Abina","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.omtm.2018.10.001_bib38","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2018.10.001_bib39","doi-asserted-by":"crossref","first-page":"335ra57","DOI":"10.1126\/scitranslmed.aad8856","article-title":"Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency","volume":"8","author":"De Ravin","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2018.10.001_bib40","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMoa1609677","article-title":"Gene Therapy in a Patient with Sickle Cell Disease","volume":"376","author":"Ribeil","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2018.10.001_bib41","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.omtm.2018.10.001_bib42","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1182\/blood-2010-04-278234","article-title":"Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model","volume":"116","author":"Visigalli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.10.001_bib43","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0301-472X(99)00098-3","article-title":"A genetically myeloablated MPS VII model detects the expansion and curative properties of as few as 100 enriched murine stem cells","volume":"27","author":"Soper","year":"1999","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.omtm.2018.10.001_bib44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2013.09.008","article-title":"High-dose enzyme replacement therapy in murine Hurler syndrome","volume":"111","author":"Ou","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2018.10.001_bib45","first-page":"1895","article-title":"Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-L-iduronidase deficiency","volume":"93","author":"Lutzko","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.10.001_bib46","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1089\/hum.1998.9.16-2375","article-title":"Long-term expression, systemic delivery, and macrophage uptake of recombinant human glucocerebrosidase in mice transplanted with genetically modified primary myoblasts","volume":"9","author":"Liu","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2018.10.001_bib47","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ymthe.2006.01.006","article-title":"Gene therapy for lysosomal storage diseases","volume":"13","author":"Sands","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2018.10.001_bib48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1182\/asheducation-2009.1.147","article-title":"Determinants of platelet number and regulation of thrombopoiesis","volume":"2009","author":"Kaushansky","year":"2009","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.omtm.2018.10.001_bib49","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2004-02-0703","article-title":"BMP4 and Madh5 regulate the erythroid response to acute anemia","volume":"105","author":"Lenox","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.10.001_bib50","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1172\/JCI41291","article-title":"Murine erythroid short-term radioprotection requires a BMP4-dependent, self-renewing population of stress erythroid progenitors","volume":"120","author":"Harandi","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2018.10.001_bib51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13023-017-0662-9","article-title":"Open issues in Mucopolysaccharidosis type I-Hurler","volume":"12","author":"Parini","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2018.10.001_bib52","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2015.02.011","article-title":"Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines","volume":"21","author":"Aldenhoven","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2018.10.001_bib53","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V13.8.789.789","article-title":"The life span of red cells in the rat and the mouse as determined by labeling with DFP32 in\u00a0vivo","volume":"13","author":"Van Putten","year":"1958","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.10.001_bib54","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","article-title":"Programmed anuclear cell death delimits platelet life span","volume":"128","author":"Mason","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2018.10.001_bib55","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/175552b0","article-title":"Determination of the life of human blood platelets using labelled diisopropylfluorophosphanate","volume":"175","author":"Leeksma","year":"1955","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2018.10.001_bib56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3324\/haematol.2010.035287","article-title":"Determinants of platelet count in humans","volume":"96","author":"Daly","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2018.10.001_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-291X(74)80349-9","article-title":"In\u00a0vitro correction of deficient human fibroblasts by beta-glucuronidase from different human sources","volume":"57","author":"Brot","year":"1974","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2018.10.001_bib58","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1073\/pnas.74.5.2026","article-title":"Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts","volume":"74","author":"Kaplan","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2018.10.001_bib59","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1073\/pnas.76.9.4322","article-title":"Enzymatic identification of mannose 6-phosphate on the recognition marker for receptor-mediated pinocytosis of beta-glucuronidase by human fibroblasts","volume":"76","author":"Natowicz","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2018.10.001_bib60","doi-asserted-by":"crossref","first-page":"e0189309","DOI":"10.1371\/journal.pone.0189309","article-title":"Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients","volume":"12","author":"Rohner","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050118300974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050118300974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T00:08:18Z","timestamp":1572048498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050118300974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":60,"alternative-id":["S2329050118300974"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2018.10.001","relation":{},"ISSN":["2329-0501"],"issn-type":[{"type":"print","value":"2329-0501"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Getting the Most: Enhancing Efficacy by Promoting Erythropoiesis and Thrombopoiesis after Gene Therapy in Mice with Hurler Syndrome","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2018.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s).","name":"copyright","label":"Copyright"}]}}